Related Experiment Video
Updated: Jun 22, 2026

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
Published on: August 25, 2023
Kinome profiling in pediatric brain tumors as a new approach for target discovery
Arend H Sikkema1, Sander H Diks, Wilfred F A den Dunnen
1Department of Pediatric Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Abstract:
Progression in pediatric brain tumor growth is thought to be the net result of signaling through various protein kinase-mediated networks driving cell proliferation. Defining new targets for treatment of human malignancies, without a priori knowledge on aberrant cell signaling activity, remains exceedingly complicated. Here, we introduce kinome profiling using flow-through peptide microarrays as a new concept for target discovery. Comprehensive tyrosine kinase activity profiles were identified in 29 pediatric brain tumors using the PamChip kinome profiling system. Previously reported activity of epidermal growth factor receptor, c-Met, and vascular endothelial growth factor receptor in pediatric brain tumors could be appreciated in our array results. Peptides corresponding with phosphorylation consensus sequences for Src family kinases showed remarkably high levels of phosphorylation compared with normal tissue types. Src activity was confirmed applying Phos-Tag SDS-PAGE. Furthermore, the Src family kinase inhibitors PP1 and dasatinib induced substantial tumor cell death in nine pediatric brain tumor cell lines but not in control cell lines. Thus, this study describes a new high-throughput technique to generate clinically relevant tyrosine kinase activity profiles as has been shown here for pediatric brain tumors. In the era of a rapidly increasing number of small-molecule inhibitors, this approach will enable us to rapidly identify new potential targets in a broad range of human malignancies.
Insights
New kinome profiling identifies Src family kinases as key drivers in pediatric brain tumors. This high-throughput method rapidly discovers potential therapeutic targets for various cancers.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Pediatric brain tumor growth is driven by complex protein kinase signaling networks.
- Identifying novel therapeutic targets is challenging without understanding aberrant cell signaling.
- Kinome profiling offers a potential solution for target discovery in malignancies.
Purpose of the Study:
- To introduce and validate kinome profiling using flow-through peptide microarrays for pediatric brain tumor target discovery.
- To identify specific tyrosine kinase activity profiles in pediatric brain tumors.
- To assess the therapeutic potential of targeting identified kinases.
Main Methods:
- Utilized the PamChip kinome profiling system on 29 pediatric brain tumors.
- Analyzed tyrosine kinase activity profiles and phosphorylation consensus sequences.
- Confirmed Src activity using Phos-Tag SDS-PAGE.
- Tested Src family kinase inhibitors (PP1, dasatinib) on pediatric brain tumor cell lines.
Main Results:
- Comprehensive tyrosine kinase activity profiles were generated for pediatric brain tumors.
- Previously known kinase activities (EGFR, c-Met, VEGFR) were confirmed.
- Significantly elevated phosphorylation of Src family kinase substrates was observed.
- Src family kinase inhibitors demonstrated significant tumor cell death in pediatric brain tumor cell lines.
Conclusions:
- Kinome profiling is a novel, high-throughput technique for generating clinically relevant kinase activity profiles.
- This approach successfully identified Src family kinases as critical in pediatric brain tumors.
- The findings highlight a new strategy for rapid identification of therapeutic targets in diverse human malignancies.
More Related Videos
09:24Generation of Microtumors Using 3D Human Biogel Culture System and Patient-derived Glioblastoma Cells for Kinomic Profiling and Drug Response Testing
Published on: June 9, 2016
07:44Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device
Published on: May 2, 2025
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...